Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C07
ORGANIC CHEMISTRY
Load children
C07C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
Load children
311/00
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Load children Filter patents View analytics View as hierarchy Open in page
C07C311/01
Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
Load children Filter patents View analytics View as hierarchy Open in page
C07C311/02
of an acyclic saturated carbon skeleton
Load children Filter patents View analytics View as hierarchy Open in page
C07C311/03
having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
Load children Filter patents View analytics View as hierarchy Open in page

C07C311/03

RESIST COMPOSITION AND PATTERN FORMING PROCESS
20210278763 · 2021-09-09 · ·

A resist composition comprising a quencher containing a sulfonium salt having the formula (A).

##STR00001##

RESIST COMPOSITION AND PATTERN FORMING PROCESS
20210278763 · 2021-09-09 · ·

A resist composition comprising a quencher containing a sulfonium salt having the formula (A).

##STR00001##

COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
20210130301 · 2021-05-06 · ·

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
20210130301 · 2021-05-06 · ·

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

Compositions for the treatment of pulmonary fibrosis
10919863 · 2021-02-16 · ·

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

Compositions for the treatment of pulmonary fibrosis
10919863 · 2021-02-16 · ·

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

Biaryl urea derivative or salt thereof and preparation process and use for the same
10851050 · 2020-12-01 · ·

The present disclosure discloses a biaryl urea RORt inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an RORt inhibiting activity, and a preparation process thereof, and a pharmaceutical composition comprising the compound. Further disclosed is use of the compound for treating an RORt-related disease. ##STR00001##

Biaryl urea derivative or salt thereof and preparation process and use for the same
10851050 · 2020-12-01 · ·

The present disclosure discloses a biaryl urea RORt inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an RORt inhibiting activity, and a preparation process thereof, and a pharmaceutical composition comprising the compound. Further disclosed is use of the compound for treating an RORt-related disease. ##STR00001##

BIARYL UREA DERIVATIVE OR SALT THEREOF AND PREPARATION PROCESS AND USE FOR THE SAME
20200239411 · 2020-07-30 ·

The present disclosure discloses a biaryl urea RORt inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an RORt inhibiting activity, and a preparation process thereof, and a pharmaceutical composition comprising the compound. Further disclosed is use of the compound for treating an RORt-related disease.

##STR00001##

BIARYL UREA DERIVATIVE OR SALT THEREOF AND PREPARATION PROCESS AND USE FOR THE SAME
20200239411 · 2020-07-30 ·

The present disclosure discloses a biaryl urea RORt inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an RORt inhibiting activity, and a preparation process thereof, and a pharmaceutical composition comprising the compound. Further disclosed is use of the compound for treating an RORt-related disease.

##STR00001##